Annji Pharmaceutical Co's total inventories for the quarter that ended in Dec. 2025 was NT$18.11 Mil. Annji Pharmaceutical Co's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was NT$22.76 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Annji Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was NT$0.92.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Annji Pharmaceutical Co's Days Inventory for the
six
months ended in Dec. 2025 was 29,050.04.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Annji Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.01.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Annji Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 54.33.
Annji Pharmaceutical Co (ROCO:7754) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Annji Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Annji Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Annji Pharmaceutical Co Total Inventories Related Terms
Annji Pharmaceutical Co Total Inventories Historical Data
* Premium members only.
The historical data trend for Annji Pharmaceutical Co's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Annji Pharmaceutical Co Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of NT$18.11 Mil mean?
Annji Pharmaceutical Co (ROCO:7754) has a Total Inventories of NT$18.11 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Annji Pharmaceutical Co and its competitors.
Is Annji Pharmaceutical Co's Total Inventories too high?
Annji Pharmaceutical Co's current Total Inventories is NT$18.11 Mil. Overall, Annji Pharmaceutical Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Annji Pharmaceutical Co's Total Inventories compare to VRTX and REGN?
Annji Pharmaceutical Co's Total Inventories of NT$18.11 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Annji Pharmaceutical Co and its competitors. Annji Pharmaceutical Co's current Total Inventories is NT$18.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annji Pharmaceutical Co stock overvalued right now?
Annji Pharmaceutical Co (ROCO:7754) has a current Total Inventories of NT$18.11 Mil. The current Total Inventories is NT$18.11 Mil. Annji Pharmaceutical Co's overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Annji Pharmaceutical Co (ROCO:7754), the current Total Inventories is NT$18.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.
9GF Score
Get the complete analysis for ROCO:7754
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7754 has been successfully added to your 